Abstract | OBJECTIVE: To express a full-length human-mouse chimeric anti-DR5 antibody from a single open reading frame with tumoricidal activity to various cancer cells. METHODS: The heavy and light chains of chimeric antibody were joined by the Furin and 2A (F/2A) self-cleavage peptide and cloned into a lentiviral vector of pWPXL. Then the HEK293 cells were infected with the constructed expression vector pWPXL-HF2AL. Western blot, enzyme-linked immunosorbent assay (ELISA) and MTS assay were used to detect the chimeric antibody expression, cleavage, binding affinity to the antigen and tumoricidal activity to various tumor cells. RESULTS: The recombinant chimeric antibody was successfully expressed from a single open reading frame in pWPXL-HF2AL construct. And it possessed a similar binding affinity to the parental murine counterpoint and strong tumoricidal activity to various cancer cells. For example, on the concentration of 3 µg/ml, it made the relative cells viability of HCT116, SMMC7721, A549 and U251 down to 20.6% ± 2.6%, 35.1% ± 2.7%, 76.1% ± 6.1% and 15.6% ± 2.0% respectively. CONCLUSIONS: The human-mouse chimeric anti-DR5 antibody of F/2A peptide is successfully expressed. Possessing a strong tumoricidal activity in various cancer cells, it may provide a novel strategy for cancer biotherapy.
|
Authors | Meng Li, Fu-jia Lü, Juan Shi, Yan-xin Liu, De-xian Zheng |
Journal | Zhonghua yi xue za zhi
(Zhonghua Yi Xue Za Zhi)
Vol. 91
Issue 10
Pg. 707-10
(Mar 15 2011)
ISSN: 0376-2491 [Print] China |
PMID | 21600181
(Publication Type: English Abstract, Journal Article)
|
Chemical References |
- Antibodies
- Antineoplastic Agents
- Recombinant Fusion Proteins
- Furin
|
Topics |
- Animals
- Antibodies
(genetics, metabolism)
- Antineoplastic Agents
(metabolism)
- Blotting, Western
- Enzyme-Linked Immunosorbent Assay
- Furin
(metabolism)
- Genetic Vectors
- HEK293 Cells
- Humans
- Mice
- Recombinant Fusion Proteins
(biosynthesis, metabolism)
- Transfection
|